Drug Education Guide

Atezolizumab (Patient)

Immunotherapy Monoclonal antibody PD-L1 inhibitor

Atezolizumab (Patient)

Immunotherapy Monoclonal antibody PD-L1 inhibitor
Light Sensitive Fall Risk
Medication Basics

Drug Name

Atezolizumab. This education entry is the patient version.

Purpose / Indication

Atezolizumab is used to treat selected cancers including lung cancer, liver cancer, melanoma, and other eligible tumors. Your oncology team will explain why this medicine is part of your treatment plan.

Dosage & Administration

Dose Schedule

The dose and schedule depend on the cancer type, treatment plan, body size, lab results, and provider orders.

Route

IV (Intravenous)

Timing Considerations

This medication is usually given in an infusion center. Plan for extra time for assessment, premedications, infusion, and monitoring.

Food Relation

Either

Time of Day

Flexible

Special Instructions

Tell your care team about allergies, infections, new symptoms, pregnancy concerns, vaccines, and all medicines or supplements you take.

Injection Techniques

This medication is administered by trained healthcare professionals.

Mechanism of Action

Mechanism

Atezolizumab works by affecting PD-L1 checkpoint pathway, which helps slow or kill cancer cells or helps the immune system fight cancer.

13 More Sections — Members Only

Free membership unlocks the complete guide.

  • Side Effects
  • Drug Interactions
  • Contraindications
  • Monitoring
  • Adherence
  • + 8 more…